MedPath

Dexamethasone versus neostigmine as an adjuvant to bupivcaine 0.25% for caudal analgesia in children undergoing open inguinal hernia repair

Not Applicable
Conditions
Surgery
congenital inguinal hernia in children
Registration Number
PACTR201606001632982
Lead Sponsor
tanta university hospitals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
96
Inclusion Criteria

children aged 2-8 years, of either gender, ASA I-II, undergoing elective surgeries for inguinal hernia repair will be enrolled in the study.

Exclusion Criteria

Patients with the following conditions will excluded from the study:
1- Infection at the injection site.
2- coagulapathy
3-prexisting neurological diseases
4- Congenital anomalies
5- Allergy to one of the study drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the primary outcome of this study will be to compare the duration of postoperative analgesia of caudal block when dexamethasone and neostigmine will be added to bupivacaine 0.25% in children.
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes will be the hemodynamic stability and postoperative complications.
© Copyright 2025. All Rights Reserved by MedPath